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Purpose: To develop the quantitative structure-activity relationship (QSAR) for predicting the 
anticonvulsant activity of α-substituted acetamido-N-benzylacetamide derivatives. 
Methods: AM1 semiempirical quantum chemical calculation method was used to find the optimum 3D 
geometry of the studied molecules. Two types of molecular descriptors, including the 2D autocorrelation 
and GETAWAY descriptors, were used to derive a quantitative relation between anticonvulsant activity 
and structural properties. The relevant molecular descriptors were selected by genetic algorithm-based 
multiple linear regression (GA-MLR) approach. 
Results: The high value of the correlation coefficient, R
2
 (0.900), indicate that the model was 
satisfactory.  
Conclusion:  The proposed model has good stability, robustness and predictability when verified by 
internal and external validation. 
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INTRODUCTION 
 
Epilepsy, a common neurological disorder 
characterized by recurrent spontaneous 
seizures arising from excessive electrical 
activity in some portion of the brain, is a 
worldwide public health problem which 
affects approximately 1 % of the population 
[1]. Over the years, the field of epilepsy has 
received a great deal of attention from 
research investigators in the hope of 
discovering new drugs that are more effective 
and have minimal adverse effects. Though 
several new anticonvulsants have been 
introduced, some types of epilepsies are still 
not adequately controlled with the current 
therapy. Adverse reactions and lack of 
efficacy for certain types of epilepsies are 
some of the limitations of existing 
medications [2]. Antiepileptic drugs exert their 
action by different mechanisms. They include 
an enhancement of the GABA-ergic 
neurotransmission, effects on neuronal 
voltage-gated sodium and/or calcium 
channels [3] 
 
Quantitative structure-activity relationships 
(QSAR), as a major factor in drug design, are 
mathematical equations relating chemical 
structure to their biological activity [4]. 
Anticonvulsant agents have been the aim of 
many SAR and QSAR studies [5-16]. 
Palludotto et al [5] synthesized a series of 2-
aryl-2,5-dihydropyridazino[4,3-b]indol-3-one 
derivatives and tested them as central 
benzodiazepine receptor ligands . These 
workers used 2D and 3D QSAR on these 
molecules and observed that the molar 
refractivity (MR) of the substituents was the 
major factor controlling the binding of the 
ligands to their receptors. A correlation 
between the theoretical descriptors of the 
tricyclic neuro-active drugs and their 
biological mode of action has been obtained 
by the theoretical studies of Marone and 
coworkers [6]. Three dimensional QSAR 
analyses on the anticonvulsant activity of a 
series of cinnamamides using comparative 
molecular field analysis (CoMFA) and 
comparative molecular similarity indices 
analysis (CoMSIA) approaches have been 
reported by Hou et al. [7]. These investigators 
found that the interaction of these 
compounds with receptors is achieved by 
electrostatic and hydrophobic forces. Marder 
et al [8] have reported molecular modeling 
and QSAR analysis of flavone derivatives 
upon interaction with benzodiazepine binding 
site. The electronic properties of the ligands 
were found to be the major factor affecting 
the ligand-receptor binding [9]. 
 
In the present study, we aimed to develop 
QSAR equations for the anticonvulsant 
activity of a series of α- substituted 
acetamido-N-benzylacetamide drugs. We 
therefore used two types of molecular 
descriptors including 2D Autocorrelation and 
GETAWAY parameters to derive a 
quantitative relation between the 
anticonvulsant activity and structural 
descriptors obtained by genetic algorithm-




Activity data  
 
A data set containing α- substituted 
acetamido-N-benzylacetamide drugs was 
used in this study. The ED50 (mg/kg) data of 
the anticonvulsant activity, were evaluated by 
the maximal electroshock seizure (MES test) 
by Kohn et al [17], were taken from the paper 
of Jin et al.[11]. The supposed 
benzylacetamide anticonvulsant pharmaco-
phore consists of a vicinal diamine linkage; 
an oxygen atom on the ethylene chain 
bridging two amino groups; and an aromatic 
ring one carbon removed from an amide 
group. The chemical structure and 
anticonvulsant activity of the studied 
molecules are included in Figure 1 and Table 
1.  
 
2D Autocorrelation approach 
 
Three spatial 2D autocorrelation (2DAUTO) 
vectors were employed for modeling [18]: 
Broto-Moreau’s autocorrelation coefficients: 
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1 CH3 CH2-Ph 1.88 1.95 
2
 a 
CH3 CH2-Ph-m-F 1.89 1.85 
3 2-Furanyl CH2-Ph-o-F 1.60 1.41 
4 2-Furanyl CH2-Ph-m-F 1.12 1.13 
5
 a 
2-Furanyl CH2-Ph-p-F 1.10 1.17 
6 2-Furanyl CH2-2,5-F2C6H3 1.38 1.58 
7 2-Furanyl CH2-2,6-F2C6H3 1.80 1.80 
8 3-Allyl CH2-Ph 1.53 1.58 
9 2-Tetrahydrofuranyl CH2-Ph 1.71 1.56 
10
 
Ph CH2-Ph 1.31 1.56 
11 2-Furanyl CH2-Ph 1.01 1.07 
12 2-Furanyl-5-CH3 CH2-Ph 1.28 1.20 
13
 a 
2-Pyrrolyl CH2-Ph 1.21 1.36 
14 2-Pyrrolyl-5-CH3 CH2-Ph 1.56 1.60 
15
 a 
2-Thienyl CH2-Ph 1.65 1.54 
16 3-Thienyl CH2-Ph 1.94 1.82 
17
 a
  1-Pyrrole CH2-Ph 1.90 1.75 
18
 
1-Pyrazole CH2-Ph 1.22 1.33 
19 2-Pyridyl CH2-Ph 1.03 1.05 
20 C(S)NH2 CH2-Ph 1.94 1.99 
21 NHCH2CH3 CH2-Ph 1.63 1.57 
22 N(CH3)2 CH2-Ph 1.66 1.81 
23
 a
 N(CH3)OH CH2-Ph 1.48 1.34 
24 NPhNH2 CH2-Ph 1.63 1.57 
25 OH CH2-Ph 1.90 1.98 
26 OCH2CH3 CH2-Ph 1.79 1.73 
27
 a 
CH2OCH3 CH2-Ph 0.92 0.97 
28 CH2OCH2CH3 CH2-Ph 1.23 1.21 
29
 a 
2-Pyrazinyl CH2-Ph 1.17 1.24 
30 2-Pyrimidyl CH2-Ph 0.91 0.85 
31
 a 
2-Oxazole CH2-Ph 1.02 0.91 
32
 a
 2-Thiazole CH2-Ph 1.08 1.14 













2-Furan CH2-Ph 1.48 1.50 
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 ………………. (3) 
where lATSw , lMATSw , and lGATSw  are 
Broto- Moreau’s autocorrelation coefficient, 
Moran’s index, and Geary’s coefficient at 
spatial lag l, respectively; where iw  and jw  
are the values of any atomic property of atom 
i and j respectively; w  is the average value 
of property; L is the number of nonzero 
values in the sum, N is the number of atoms 
in the molecule, and )dδ(l, ij  is a Dirac-delta 

















where dij is the topological distance or spatial 
lag between atoms i and j. 
 
The 2D Autocorrelation descriptors in general 
explain how the considered property is 
distributed along the topological structure. 
Autocorrelation vectors were calculated at 
spatial lags l ranging from 1 up to 8. The 
physicochemical property considered in the 
four different weighting schemes: atomic 
masses (m), atomic van der Waals volumes 
(v), atomic Sanderson electronegativities (e), 
and atomic polarizabilities (p). The 
autocorrelation descriptors are denoted by 
the scheme: type of descriptor-spatial lag-
weighting property; for instance, GATS5p is 
the Geary autocorrelation of lag 5 weighted 




The GETAWAY descriptors [19] are recently 
proposed molecular descriptors derived from 
a new representation of molecular structure, 
the molecular influence matrix (MIM), 








 ………………. (5) 
 
where M is the molecular matrix constituted 
by the centered Cartesian coordinates x, y, z 
of the molecule atoms (hydrogens included) 
in a chosen conformation, and the superscript 
T refers to the transposed matrix.  
 
On the other hand, matrix R, a symmetrical 
matrix whose elements resemble the single 
terms in the sums of the gravitational indices, 
















R , i ≠ j,  …………….. (6) 
Where hii and hjj are the leverages of the two 
considered atoms and rij their geometric 
distance. Obviously, the diagonal elements of 
matrix R are zero, and the largest values of 
its off-diagonal elements derive from the most 
external atoms (i.e., with high leverages) and 
simultaneously next to each other in the 
molecular space (i.e., small interatomic 
distance).  
 
Finally notice that, in many of these H and R 
descriptors, the molecule atoms are weighted 
in such a way as to account for atomic mass, 
polarizability, van der Waals volume, and 
electronegativity, with the aim of incorpora-
ting relevant chemical information. Two sets 
of theoretically closely related molecular 
descriptors have been devised: H-GETAWAY 
descriptors have been calculated from the 
MIM H, while R-GETAWAY descriptors are 
from the influence/distance matrix R where 
the elements of the MIM are combined with 




HyperChem software was used to draw the 
chemical structure of the molecules. AM1 
semi-empirical quantum-chemical calculation 
was used to optimize the 3D geometry of the 
molecules. The geometry optimization was 
preceded by the Polak-Rebiere algorithm 
until the root mean square gradient reaches 
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0.01. Dragon [20] computer software was 
employed to calculate the 2DAUTO and 
GETAWAY molecular descriptors.  
 
The calculation of weighted Broto-Moreau, 
Moran, and Geary 2DAUTO vectors was 
carried out at spatial lags ranging from 1 to 8. 
Four different weighting properties including 
atomic masses (m), atomic van der Waals 
volumes (v), atomic Sanderson 
electronegativities (e), and atomic 
polarizabilities (p) were used. Since we 
calculated three types of autocorrelation 
descriptors (Moran’s index, Geary’s 
coefficient, and Broto-Moreau’s 
autocorrelation coefficient) weighted by 4 
atomic properties at 8 lags, a total of 96 (3 × 
4 × 8) descriptors for each compound were 
computed.  
 
Two sets of GETAWAY descriptors including 
H-GETAWAY and the R-GETAWAY 
descriptors have been calculated. The first 
set consists of 107 H-GETAWAY descriptors 
calculated from the leverage matrix obtained 
by the centered atomic coordinates, that is, 
the molecular influence matrix (H), while the 
remaining 90 R-GETAWAY descriptors are 
calculated from the influence/ distance (R) 
matrix. 
 
The calculated descriptors were gathered in a 
data matrix. First, the descriptors were 
checked for constant or near constant values 
and those detected were discarded from the 
original data matrix. 
 
Then, the descriptors were correlated with 
each other and with the activity data. Among 
the collinear descriptors, one with the lowest 
correlation with anticonvulsant drug was 
removed from the data matrix. Multiple linear 
regressions (MLR) were used to derive the 
QSAR equation and feature selection was 
performed by the use of genetic algorithm 
(GA).  
 
A genetic algorithm is a novel and simple 
optimization method based on the evolution 
process of beings that implicitly and 
effectively has been applied to the various 
types of optimization problems in many 
scientific fields. It is based on the simulation 
of natural genetics and evolutions. The 
genetic algorithm used was the same as that 
previously used [21,22].  Each individual of 
the population was defined by a chromosome 
of binary values representing a subset of 
descriptors. A gene took a value of 1 if its 
corresponding descriptor was included in the 
subset; otherwise it took a value of zero. The 
number of genes at each chromosome was 
equal to the number of descriptors. The initial 
population was created randomly. The 
population size was varied between 50 and 
250 for different GA runs. The resulting 
models were validated by leave one- out 
(LOO) cross-validation procedures to check 
their predictability and robustness. Table 2 
presents the notation and a short description 
of the molecular descriptors used to generate 




By using the genetic algorithm-based multiple 
linear   regression   (GA-MLR)   method,   the 
 
Table 2: Description of the molecular descriptors used in this study 
 
Symbol Definition Class 
MATS6e Moran autocorrelation - lag 6 / weighted by atomic Sanderson 
electronegativities  
2D  
MATS5p Moran autocorrelation - lag 5 / weighted by atomic polarizabilities 2D  
ATS6e Broto-Moreau autocorrelation - lag 6 / weighted by atomic Sanderson 
electronegativities 
2D  
H7v H autocorrelation of lag 7 / weighted by atomic van der Waals volumes  GETAWAY  
HATS2u leverage-weighted autocorrelation of lag 2 / unweighted  GETAWAY  
H5m H autocorrelation of lag 5 / weighted by atomic masses GETAWAY 
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models were developed for 35 anticonvulsant 
analogues.  
 
The correlations performed for the whole set 
provided the optimal equations for different 
numbers of descriptors in the range of 1-6. 







(squared standard deviation) as a function of 
the number of variables in the regression 
model. 
 
Figure 1: Influence of the number of descriptors 
on the correlation coefficient (R
2
), the LOO cross-
validation correlation coefficient (Q
2
) and the 
square of standard error (s
2









It suggests that the best one-descriptor 
model with highest impact is MATS6e which 
is defined as Moran autocorrelation vector 
weighted by Sanderson electronegativities 
representing topological substructure of sizes 
6 in the molecule. Subsequent addition of 





 and decreasing values s
2
 
and the break point is not clearly defined. We 
decided to select the best model to be the 
one having the smallest number of 
parameters and satisfactory statistical 
parameters. The model with 6 descriptors: 
Log ED50 = 3.0647 (±1.1867) + 2.4601 
(±0.2293) MATS6e + 12.5149 (±1.4119) H7v 
+ 7.6953 (±1.2669) HATS2u + 3.1255 
(±0.5477) MATS5p - 3.9054 (±1.0490) 
ATS6e + 0.9969 (±0.4395) H5m............(7) 
 
N = 35, R
2
 = 0.900, SE = 0.118, RMS = 
0.107, F = 41.963, Q
2
 = 0.853...............…..(8) 
Some statistical parameters such as squared 
correlation coefficients (R
2
), standard error of 
estimation (SE), root-mean-square error 
(RMS), Fisher statistic ratio (F) and LOO 
cross-validation (Q
2
) are given in the Eq. 8. 
As can be seen, the MLR model has good 
statistical quality with low prediction error. 
The predicted activities by using GA-MLR 
regression method are listed in Table 1. 
 
The robustness of the model and their 
prediction ability for the anticonvulsant 
activity, were evaluated by both LOO cross-
validation and external validation procedures. 
In order to estimate the predictive power of 
the GA-MLR model, an external validation 
test was performed by splitting the data into 
two sub-samples with one being used to fit 
(training set) and the other to test (test set). 
Models are generated based on training set 
compounds and predictive capacity of the 
models is judged based on the predictive R
2
 
values. Selection of the training set 
compounds is significantly important in QSAR 
analysis. One most widely used method for 
dividing a data set into training and test sets 
is mere random selection.  
 
In the external validation procedure, 10 
analogues are randomly selected and 
eliminated from the data set as unknown test 
samples. Then the training set generated 
using remaining 25 samples and log (ED50) of 
eliminated samples are predicted using the 
MLR model. The test set is marked with 
superscript a in Table 1. A model based on 
training set is the following:   
Log ED50 = 3.0590 (±1.2893) + 2.4863 
(±0.2678) MATS6e + 12.4037 (±1.5221) H7v 
+ 6.9874 (±1.4062) HATS2u + 2.5769 (±0. 
7032) MATS5p - 3.6462 (±1.1633) ATS6e + 
0.8814 (±0.5393) H5m ………………….. (9) 
 
N = 25, R
2
 = 0.893, SE = 0.118, RMS = 
0.103, Q
2
 = 0.823., F = 26.760 ............... (10) 
Eq 10 was used to predict the anticonvulsant 
activity of the test set. The results are 
presented in Figure 2, which R
2
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the test set are 0.898 and 0.119, respectively. 
The results illustrated once more that the GA-
MLR technique is adequate to generate an 
efficient QSAR model for predicting the 



























Figure 2: Plot of the anticonvulsant activity 
predicted by GA-MLR for calibration set (■) and 
validation set (∆) against the experimental values. 
(Note: The solid and dashed lines are the 
calibration and validation regression lines, 
respectively, while the dotted line is an ideal fit 




The proposed QSAR model, due to the high 
predictive ability, can therefore act as a 
useful aid to the costly and time consuming 
experiments for determining the maximal 
electroshock seizure (MES test). We first 
tried to identify descriptors trends which lead 
to anticonvulsant activity based on the 
proposed QSAR equation. The QSAR model 
of α-substituted acetamido-N-benzylace-
tamide derivatives (Table 1) has shared six 
2DAUTO and GETAWAY class descriptors 
(Table 2). As mentioned before, Moran 
autocorrelation lag 6 weighted by Sanderson 
electronegativities (MATS6e) is the most 
important variable for predicting the 
anticonvulsant activity. The remaining five 
descriptors involve the summations of 
different functions corresponding to the 
different fragment lengths and with 
polarizability (p), electronegativity (e), volume 





In summary, multivariate linear QSAR models 
were obtained by MLR method combined 
with genetic algorithm for variable selection 
(GA-MLR). We have shown that the 2D 
AUTO and GETAWAY descriptors are able to 
describe the anticonvulsant activity of 
different α- substituted acetamido-N-
benzylacetamide derivatives. The proposed 
models have good stability, robustness and 
predictability when verified by internal 
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